[TENX]
Mid
Row
2026-08-31 04:04:04
Tenax finds benefit in sicker patient subgroup after Phase 3 trial miss
Mid
2026-08-29 21:30:34
Tenax presents additional Phase 3 trial data for TNX-103
Mid
2026-08-25 20:48:51
Tenax rises on over $1.8M insider buying
Row
2026-08-10 23:32:23
Tenax plummets on phase 3 failure of pulmonary hypertension drug
Mid
2026-07-31 20:08:48
Tenax Therapeutics GAAP EPS of -$0.35 beats by $0.01
1 / 2